Search for: "-CJK UNITED STATES OF AMERICA v. ABBOTT et al" Results 1 - 20 of 26
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2024, 1:45 pm by Michael Lowe
  On March 5, 2024, Justice Samuel Alito signed an Order extending a current stay to March 18, 2024, in the pending case of Cause No. 23A815, Las Americas Immigrant Advocacy Center, et al., v. [read post]
26 May 2011, 7:09 am by Lawrence B. Ebert
Merrill et al., Nat’l Research Coun- cil of the Nat’l Academies, A Patent System for the 21st Century 122 (2004). [read post]
18 Jun 2009, 5:19 pm
Obama, President of the United States, et al. [read post]
29 Jun 2009, 2:59 pm
Docket: 08-645 Title: Abbott v. [read post]
15 Jan 2008, 3:06 am
filed 03/22/07 1:07-cv-01721 Abbott Laboratories et al v. [read post]
13 Feb 2009, 8:00 am
(IPKat)   United States US General Sen Gregg withdraws from nomination to be next Secretary of Commerce (Inventive Step) (Patently-O) Influx of Big Content lawyers at Department of Justice: cause for concern? [read post]
18 Apr 2008, 2:00 am
Protecting computer programs under the Copyright Act: Dais Studios v Bullet Creative: (IP Down Under), Assessing copyright risk in new classroom technologies: (IP Down Under), Cadbury loses battle over exclusive use of colour purple for chocolate wrapping in its case against Darrell Lea: (Australian Trade Marks Law Blog), (IP Down Under), (IPKat), (IPwar’s), Employee or independent contractor? [read post]
6 Dec 2010, 2:36 am by Kelly
Fossil, Inc. et al (Docket Report) CAFC: Liability for offers to sell clarified: Transocean Offshore Deepwater Drilling, Inc. v. [read post]
27 Jun 2008, 10:04 am
Porsche AG: (Class 46), WIPO: Yell Limited v Yell.travel: domain name yell.travel to be transferred to Yell Limited: (Class 46), Some see rise in non-traditional trade marks; national registries not yet: (Intellectual Property Watch)   Global - Patents Lower patentability standards – strategic responses: (IP Thinktank), IP Business Congress sees Finnish inventor become a millionaire: (IAM), Ron Slusky: Five prescriptions for effectively analysing an invention and then… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
27 Feb 2009, 7:00 am
(The IP Factor)   Uganda Anti-counterfeits conference held in Kampala (Afro-IP)   United Kingdom IP rights in the Court of Appeal, but not as we know them...: Office of Communications v Information Commissioner (IPKat) IPO review of practice before Patent Tribunal (PatLit) Employee inventor compensation: an expensive pastime? [read post]
12 Jan 2017, 7:01 am by John Elwood
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
15 Mar 2008, 7:00 am
  Shame about the IP: (Afro-IP),Ethiopia receives US trade mark for Sidamo coffee despite opposition from Starbucks: (The IP Factor), (Afro-IP),CC licensed test for African sleeping sickness: (creativecommons.org),Update on PCT applications filed in Nigeria: (Afro-IP),Parallel imports of DVDs to be tested in South Africa: Universal City Studios v Mr Video: (Afro-IP),The W****D C*P of 2*1*: FIFA’s intellectual property rights in South Africa: (Afro-IP),Namibia to adopt… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]